Epidemiology of pediatric sarcoma in Iran

Abstract Background Pediatric sarcomas are divided into two major groups of soft‐tissue sarcomas (STSs) and malignant bone tumors (MBTs). Aims The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age...

Full description

Bibliographic Details
Main Authors: Mehdi Azizmohammad Looha, Atieh Akbari, Mohammad Esmaeil Akbari, Elaheh Zarean, Narjes Mehrvar, Soheila Khodakarim
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Cancer Reports
Subjects:
Online Access:https://doi.org/10.1002/cnr2.1660
_version_ 1811169314288435200
author Mehdi Azizmohammad Looha
Atieh Akbari
Mohammad Esmaeil Akbari
Elaheh Zarean
Narjes Mehrvar
Soheila Khodakarim
author_facet Mehdi Azizmohammad Looha
Atieh Akbari
Mohammad Esmaeil Akbari
Elaheh Zarean
Narjes Mehrvar
Soheila Khodakarim
author_sort Mehdi Azizmohammad Looha
collection DOAJ
description Abstract Background Pediatric sarcomas are divided into two major groups of soft‐tissue sarcomas (STSs) and malignant bone tumors (MBTs). Aims The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age, and histological types. Methods and Results Data was retrieved from Iran National Cancer Registry between 2008 and 2015. The dataset was classified according to the third edition of the International Classification of Childhood Cancer. The survival information was merely available for 291 (21% of total data), including 142 (49%) MBTs and 149 (51%) STSs. The age‐standardized incidence rates (ASIRs) and five‐year survival rates were calculated. Conclusion The present study is the first comprehensive study of pediatric sarcomas in Iran, in which a lower incidence and survival rate of MBTs and STSs compared with high‐income countries were found. However, the survival rates of these malignancies were higher in high‐income countries compared to Iran. This study showed the need to improve the quantity and quality of the population‐based registry in Iran for acquiring progress in the prevention and control of sarcomas.
first_indexed 2024-04-10T16:40:21Z
format Article
id doaj.art-be25bc4b8a2a45a48faf6090aede14b6
institution Directory Open Access Journal
issn 2573-8348
language English
last_indexed 2024-04-10T16:40:21Z
publishDate 2023-01-01
publisher Wiley
record_format Article
series Cancer Reports
spelling doaj.art-be25bc4b8a2a45a48faf6090aede14b62023-02-08T07:31:29ZengWileyCancer Reports2573-83482023-01-0161n/an/a10.1002/cnr2.1660Epidemiology of pediatric sarcoma in IranMehdi Azizmohammad Looha0Atieh Akbari1Mohammad Esmaeil Akbari2Elaheh Zarean3Narjes Mehrvar4Soheila Khodakarim5Biostatistics, Pediatric Pathology Research Center Research Institute for Children's Health Tehran IranCancer Research Center Shahid Beheshti University of Medical Sciences Tehran IranSurgical Oncology, Cancer Research Center Shahid Beheshti University of Medical Sciences Tehran IranBiostatistics, Department of Epidemiology and Biostatistics, School of Public Health Tehran University of Medical Sciences Shahrekord IranMAHAK Hematology Oncology Research Center MAHAK‐HORC, MAHAK Hospital Tehran IranBiostatistics, Cancer Research Center Shahid Beheshti University of Medical Sciences Tehran IranAbstract Background Pediatric sarcomas are divided into two major groups of soft‐tissue sarcomas (STSs) and malignant bone tumors (MBTs). Aims The aim of the present study was to determine the incidence and survival rate of STSs and MBTs in the Iranian population based on diagnosis date, gender, age, and histological types. Methods and Results Data was retrieved from Iran National Cancer Registry between 2008 and 2015. The dataset was classified according to the third edition of the International Classification of Childhood Cancer. The survival information was merely available for 291 (21% of total data), including 142 (49%) MBTs and 149 (51%) STSs. The age‐standardized incidence rates (ASIRs) and five‐year survival rates were calculated. Conclusion The present study is the first comprehensive study of pediatric sarcomas in Iran, in which a lower incidence and survival rate of MBTs and STSs compared with high‐income countries were found. However, the survival rates of these malignancies were higher in high‐income countries compared to Iran. This study showed the need to improve the quantity and quality of the population‐based registry in Iran for acquiring progress in the prevention and control of sarcomas.https://doi.org/10.1002/cnr2.1660epidemiologyIran national cancer registrymalignant bone tumorosteosarcomapediatric sarcomarhabdomyosarcoma
spellingShingle Mehdi Azizmohammad Looha
Atieh Akbari
Mohammad Esmaeil Akbari
Elaheh Zarean
Narjes Mehrvar
Soheila Khodakarim
Epidemiology of pediatric sarcoma in Iran
Cancer Reports
epidemiology
Iran national cancer registry
malignant bone tumor
osteosarcoma
pediatric sarcoma
rhabdomyosarcoma
title Epidemiology of pediatric sarcoma in Iran
title_full Epidemiology of pediatric sarcoma in Iran
title_fullStr Epidemiology of pediatric sarcoma in Iran
title_full_unstemmed Epidemiology of pediatric sarcoma in Iran
title_short Epidemiology of pediatric sarcoma in Iran
title_sort epidemiology of pediatric sarcoma in iran
topic epidemiology
Iran national cancer registry
malignant bone tumor
osteosarcoma
pediatric sarcoma
rhabdomyosarcoma
url https://doi.org/10.1002/cnr2.1660
work_keys_str_mv AT mehdiazizmohammadlooha epidemiologyofpediatricsarcomainiran
AT atiehakbari epidemiologyofpediatricsarcomainiran
AT mohammadesmaeilakbari epidemiologyofpediatricsarcomainiran
AT elahehzarean epidemiologyofpediatricsarcomainiran
AT narjesmehrvar epidemiologyofpediatricsarcomainiran
AT soheilakhodakarim epidemiologyofpediatricsarcomainiran